Michael Flanagan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Flanagan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bruce A. Bunnell
Department of Microbiology, Immunology and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA
1 shared publication - Gang Yu
Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808, USA
1 shared publication - Gary E. Wise
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA
1 shared publication - Hunter Brooks
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA
1 shared publication - Jeffrey M. Gimble
Stem Cell Biology Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA
1 shared publication - Maryam Rezai Rad
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA
1 shared publication
Latest Publications
- Open Access
- 21 December 2012
- Published by Wiley in Cell Proliferation
- Vol. 46 (1) , 58-66
Activation of proliferation and differentiation of dental follicle stem cells (DFSCs) by heat stress
Objectives: Adult stem cells (ASCs) remain in a slowly cycling/quiescent state under normal physiological conditions, but they can be awakened from this by certain factors, such as injury signals. Previously, our group has shown that dental follicle stem cells (DFSCs) appear to proliferate more rapidly than their non‐stem cell counterparts at elevated temperatures. The study described here has aimed to (i) elucidate optimal temperature in which to culture DFSCs, (ii) determine whether elevated temperatures could enhance differentiation capability of DFSCs and (iii) characterize stem cell and osteogenic marker expression of DFSCs at elevated temperatures.Materials and methods: DFSCs obtained from rat first molars were cultured at 37 (control), 38, 39, 40 and 41 ºC. Cell proliferation was evaluated by Alamar blue reduction assay and mean numbers of viable dissociated cells. Osteogenic differentiation was evaluated after 7 or 14 days osteogenic induction. Expression of selected marker genes was also assessed during proliferation and differentiation of the cells.Results: Increased cell proliferation was seen at heat‐stress temperatures of 38º, 39º and 40 ºC. DFSCs revealed maximal osteogenesis when cultured at 39 and 40 ºC. Moreover, some stem cell and osteogensis‐associated markers had elevated expression in heat‐stress conditions.Conclusions: Under determined heat‐stress conditions, DFSCs increased their proliferation, osteogenic differentiation and expression of some marker genes. Thus, it is likely that elevated temperature could serve as a factor to activate adult stem cells.
- 21 December 2012
- Published by Wiley in Cell Proliferation
- Vol. 46 (1) , 58-66
Open AccessActivation of proliferation and differentiation of dental follicle stem cells (DFSCs) by heat stress
Objectives: Adult stem cells (ASCs) remain in a slowly cycling/quiescent state under normal physiological conditions, but they can be awakened from this by certain factors, such as injury signals. Previously, our group has shown that dental follicle stem cells (DFSCs) appear to proliferate more rapidly than their non‐stem cell counterparts at elevated temperatures. The study described here has aimed to (i) elucidate optimal temperature in which to culture DFSCs, (ii) determine whether elevated temperatures could enhance differentiation capability of DFSCs and (iii) characterize stem cell and osteogenic marker expression of DFSCs at elevated temperatures.Materials and methods: DFSCs obtained from rat first molars were cultured at 37 (control), 38, 39, 40 and 41 ºC. Cell proliferation was evaluated by Alamar blue reduction assay and mean numbers of viable dissociated cells. Osteogenic differentiation was evaluated after 7 or 14 days osteogenic induction. Expression of selected marker genes was also assessed during proliferation and differentiation of the cells.Results: Increased cell proliferation was seen at heat‐stress temperatures of 38º, 39º and 40 ºC. DFSCs revealed maximal osteogenesis when cultured at 39 and 40 ºC. Moreover, some stem cell and osteogensis‐associated markers had elevated expression in heat‐stress conditions.Conclusions: Under determined heat‐stress conditions, DFSCs increased their proliferation, osteogenic differentiation and expression of some marker genes. Thus, it is likely that elevated temperature could serve as a factor to activate adult stem cells.
- Open Access
- 18 April 2012
- Published by Springer Nature in Biological Procedures Online
- Vol. 14 (1) , 7
Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells
Background: Adipose stem cells have a strong potential for use in cell-based therapy, but the current nucleofection technique, which relies on unknown buffers, prevents their use. Results: We developed an optimal nucleofection formulation for human adipose stem cells by using a three-step method that we had developed previously. This method was designed to determine the optimal formulation for nucleofection that was capable of meeting or surpassing the established commercial buffer (Amaxa), in particular for murine adipose stem cells. By using this same buffer, we determined that the same formulation yields optimal transfection efficiency in human mesenchymal stem cells. Conclusions: Our findings suggest that transfection efficiency in human stem cells can be boosted with proper formulation.
- 18 April 2012
- Published by Springer Nature in Biological Procedures Online
- Vol. 14 (1) , 7
Open AccessCompetitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells
Background: Adipose stem cells have a strong potential for use in cell-based therapy, but the current nucleofection technique, which relies on unknown buffers, prevents their use. Results: We developed an optimal nucleofection formulation for human adipose stem cells by using a three-step method that we had developed previously. This method was designed to determine the optimal formulation for nucleofection that was capable of meeting or surpassing the established commercial buffer (Amaxa), in particular for murine adipose stem cells. By using this same buffer, we determined that the same formulation yields optimal transfection efficiency in human mesenchymal stem cells. Conclusions: Our findings suggest that transfection efficiency in human stem cells can be boosted with proper formulation.